0001144204-18-034454.txt : 20180615 0001144204-18-034454.hdr.sgml : 20180615 20180615172225 ACCESSION NUMBER: 0001144204-18-034454 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180614 FILED AS OF DATE: 20180615 DATE AS OF CHANGE: 20180615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SALZMAN BARRY M CENTRAL INDEX KEY: 0001432179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38128 FILM NUMBER: 18903081 MAIL ADDRESS: STREET 1: 464 COMMON STREET STREET 2: SUITE 301 CITY: BELMONT STATE: MA ZIP: 02478 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc. CENTRAL INDEX KEY: 0001651407 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472568632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 212-554-4366 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 4 1 tv496606_form4.xml FORM 4 X0306 4 2018-06-14 0 0001651407 Checkpoint Therapeutics, Inc. CKPT 0001432179 SALZMAN BARRY M 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 1 0 0 0 COMMON STOCK 2018-06-14 4 A 0 16448 0.00 A 76448 D The 16,448 shares of restricted Common Stock will vest on June 14, 2021, subject to Mr. Salzman's continued service on the board on such date. Represents shares of restricted Common Stock which vest over various time periods. /s/ James F. Oliviero, Attorney-in-Fact 2018-06-15